相关实验视频
Updated: May 29, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.4K
β-阻断剂和神经精神疾病风险:系统性审查和元分析
Lujain Ez Eddin1,2, Rebecca Preyra2, Fatemeh Ahmadi1,3
1ICES Western, London, ON, Canada.
British journal of clinical pharmacology
|December 10, 2024
概括
贝塔抑制剂的使用与神经精神病学的副作用增加有关,如头和失眠,特别是在脂友型患者中. 由于研究的局限性和的潜在心血管原因,需要进一步的研究.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
- 神经科学是一个神经科学.
背景情况:
- 贝塔抑制剂广泛用于心血管疾病.
- 神经精神病学不良事件是β-阻断剂治疗的潜在副作用.
- 了解这些风险对于患者安全和治疗优化至关重要.
研究的目的:
- 系统地审查和元分析β阻断剂使用与短期神经精神病学不良事件之间的关联.
- 为了确定与β抑制剂治疗相关的特定神经精神病学结果.
- 调查脂友性在这些不良事件中的作用.
主要方法:
- 对随机对照试验和观察性研究进行全面的文献搜索.
- 计算相对风险 (RR) 和95%信心区间 (CI) 的元分析.
- 专注于结果,包括头,失眠,梦,嗜睡和妄想.
主要成果:
- 使用β-阻断剂显著增加了头的风险 (RR 1.72).
- 脂性β-阻断剂,特别是普拉诺洛尔,表现出更高的头风险 (RR 3.13) 和失眠 (RR 1.13).
- 没有观察到梦或昏昏欲睡的统计学上显著增加;注意到其他影响,如昏昏欲睡.
结论:
- 贝塔抑制剂的使用与神经精神疾病风险增加有关,特别是头和失眠,而脂性药物具有更高的风险.
- 的心血管起源不能被排除,需要谨慎地解释研究结果.
- 显著的研究局限性,包括1996年之前的出版物和偏见的高风险,突出了当代,严格的研究的需要.
相关概念视频
01:25Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers
β-adrenergic antagonists, or β-blockers, modulate the sympathetic nervous system by targeting β-adrenoceptors and inhibiting catecholamine-mediated sympathetic responses. β-blockers differ in their adrenoceptor subtype affinity, lipophilicity, and α-blocking capabilities. The history of β-blocker development began with the prototype, dichloroisoprenaline, which exhibited partial agonist activity. As a result, propranolol was developed as a pure antagonist but nonselective agent, paving the way...
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
01:28Antihypertensive Drugs: Types of β-Blockers
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:26Anxiolytic Drugs: Overview
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.